TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TRAX

First Tracks Biotherapeutics, Inc.

Healthcare · Biotechnology · —

34.40$ -3.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement TRAX
Line item 2023 2024 2025
– – –
– – -8.4%
– – –
– +56.1% -8.4%
– +37.8% +37.0%
– -75.7% +37.0%
– – –
– – –
– – –
– – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?